title: [Cardiotoxicity of antineoplastic drugs].
abstract: Anticancer drugs, especially anthracyclines, may induce adverse cardiac effects which can be life-threatening in some patients. In this article we discuss the mechanisms and the types of cardiotoxicity and its prevention, with special attention paid to the role of monitoring of the cardiovascular system during chemotherapy.
authors: Zakładu Farmakologii Klinicznej AM, Lodzi.
authors: J
authors: J
authors: Drzewoski
authors: J
authors: J
authors: Kasznicki
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D016903:Drug Monitoring; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Kardiotoksyczność leków przeciwnowotworowych.